In cancer patients, NK cells can recognize and eliminate tumor cells by releasing cytolytic molecules perforin and granzymes, as well as modulate the adaptive anti-tumor immune response by producing chemokines and cytokines such as IFN-γ, TNF-α, IL-8, IL-10, and CCL2 [106]. The gene discussed is CCL2; the disease is neoplasm.